Literature DB >> 8627690

Molecular genetic analysis of Epstein-Barr virus Cp promoter function.

T J Evans1, P J Farrell, S Swaminathan.   

Abstract

The Cp promoter of Epstein-Barr virus (EBV) directs most transcription of the EBNA genes in lymphoblastoid cell lines. The functions of two control regions in the Cp promoter have been studied by construction of recombinant EBV strains containing specific mutations in these elements. Mutation of the RBP-Jk (CBF1) binding site reduced but did not completely abolish EBNA-2-dependent Cp activity in transient transfection assays. The same mutation in recombinant virus gave only a modest average reduction in Cp function, ranging from full activity to almost no activity in different isolates. Separate deletion of a 262-bp region containing glucocorticoid response elements had little effect in a transient assay but caused a fivefold increase in the steady-state level of Cp RNA in recombinant virus. The results indicate that other elements in addition to the intensively studied RBP-Jk site are important in determining Cp activity in the whole virus. Clonal EBV-infected cell lines expressed RNA from both the Cp and Wp promoters, but the level of Wp RNA did not simply compensate for changes in the level of Cp RNA. The levels of EBNA proteins varied much less than the levels of Cp and Wp RNA, suggesting other types of control in addition to initiation of transcription. A survey of RNAs derived from the internal repeat region of the virus indicated that gene expression from this region of EBV in lymphoblastoid cell lines is accounted for by the known transcripts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627690      PMCID: PMC189993     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Evidence for a functional glucocorticoid responsive element in the Epstein-Barr virus genome.

Authors:  C Schuster; S Chasserot-Golaz; G Urier; G Beck; A Sergeant
Journal:  Mol Endocrinol       Date:  1991-02

2.  Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.

Authors:  S Swaminathan; B Tomkinson; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

3.  EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.

Authors:  N S Sung; S Kenney; D Gutsch; J S Pagano
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Pathways of activation of the Epstein-Barr virus productive cycle.

Authors:  A J Sinclair; M Brimmell; F Shanahan; P J Farrell
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Identification of a glucocorticoid-responsive element in Epstein-Barr virus.

Authors:  S R Kupfer; W C Summers
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element.

Authors:  C Meitinger; L J Strobl; G Marschall; G W Bornkamm; U Zimber-Strobl
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.

Authors:  R J Tierney; N Steven; L S Young; A B Rickinson
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.

Authors:  S R Grossman; E Johannsen; X Tong; R Yalamanchili; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

9.  EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.

Authors:  P D Ling; J J Hsieh; I K Ruf; D R Rawlins; S D Hayward
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.

Authors:  M Woisetschlaeger; X W Jin; C N Yandava; L A Furmanski; J L Strominger; S H Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

View more
  22 in total

1.  Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus.

Authors:  P R Smith; O de Jesus; D Turner; M Hollyoake; C E Karstegl; B E Griffin; L Karran; Y Wang; S D Hayward; P J Farrell
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Authors:  D Salamon; M Takacs; D Ujvari; J Uhlig; H Wolf; J Minarovits; H H Niller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.

Authors:  L Yoo; S H Speck
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.

Authors:  E M Fuentes-Pananá; R Peng; G Brewer; J Tan; P D Ling
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.

Authors:  S A Radkov; M Bain; P J Farrell; M West; M Rowe; M J Allday
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Chromatin profiling of Epstein-Barr virus latency control region.

Authors:  Latasha Day; Charles M Chau; Michael Nebozhyn; Andrew J Rennekamp; Michael Showe; Paul M Lieberman
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

7.  Multiple functions within the Epstein-Barr virus EBNA-3A protein.

Authors:  I Cludts; P J Farrell
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.

Authors:  M T Puglielli; M Woisetschlaeger; S H Speck
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.

Authors:  L I Yoo; M Mooney; M T Puglielli; S H Speck
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

10.  Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.

Authors:  E M Fuentes-Pananá; P D Ling
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.